83
Participants
Start Date
August 31, 2011
Primary Completion Date
April 7, 2017
Study Completion Date
April 7, 2017
recMAGE-A3 + AS15 ASCI
5 doses were administered (intramuscular) at 3-week intervals followed by 8 doses administered at 3-month intervals for a total maximum duration of study treatment administration of 27 months
Placebo
5 doses were administered (intramuscular) at 3-week intervals followed by 8 doses administered at 3-month intervals for a total maximum duration of study treatment administration of 27 months
Faculty teaching Hospital in Plzen, Pilsen
Hospital Motol, Prague
Thomayerova nemocnice, Prague
Krajska zdravotni, a.s. - Masarykova nemocnice v Usti nad Labem, o.z., Ústí nad Labem
Institut Bergonié, Bordeaux
Hôpital Huriez, Lille
Hôpital Edouard Herriot, Lyon
Institut Curie, Paris
Hôpital Rangueil, Toulouse
Universitätsklinikum Aachen, Aachen
Universitätsklinikum C.-G. Carus Dresden, Dresden
Heinrich-Heine University, Düsseldorf
Waldkrankenhaus St. Marien gGmbH, Erlangen
Universitätsklinikum Giessen, Giessen
Universitätsklinikum Jena, Jena
Universitätsmedizin, Mannheim
Universitätsklinikum Marburg, Marburg
Klinikum rechts der Isar der TU München, München
Universitätklinikum Rostock, Rostock
Universitätsklinikum Tübingen, Tübingen
Universitaria Policlinico Consorziale di Bari, Bari
Università Vita e Saluta, Milan
Ospedaliera di Perugia, Perugia
Universitaria Pisana, Pisa
Università di Roma, La Sapienza, Rome
NKI, Amsterdam
St Antoniusziekenhuis, Nieuwegein
RadboudUMC, Nijmegen
Kliniczny Dzial Urologii Swietokrzyskiego Centrum Onkologii, Kielce
Medical University of Warsaw, Warsaw
Oddzial Urologii Miedzyleski Szpital Specjalistyczny w Warszawie, Warsaw
Fundeni Clinical Institute, Bucharest
Clinical County Emergency Hospital Craiova, Craiova
"Federal State Budget Institution Scientific Research Institute of Urology of the Ministry of Healthcare and Social Development of the Russian Federation", Moscow
"Federal State Institution Moscow Research Oncology Institute named after P.A. Gertsen of the Ministry of Healthcare and Social Development of the Russian Federation", Moscow
Institution of the Russian Academy of Medical Science Russian Oncology Research Center named after N.N. Blokhin of RAMS, Moscow
"Municipal Budget Institution of Health Care Clinical Diagnostic Center Zdorovie of Rostov-on-Don city", Rostov-on-Don
"Saint Petersburg State Institution of Health Care City Multi-Field Hospital #2", Saint Petersburg
Hospital Universitario A Coruña, A Coruña
Hospital Universitario Principe de Asturias, Alcalá de Henares
Hospital Universitario Fundación Alcorcón, Alcorcón
Fundación Puigvert, Barcelona
Hospital Clinic Barcelona, Barcelona
Hospital del Mar, Barcelona
Hospital Universitario Puerta del Mar, Cadiz
Hospital 12 de Octubre, Fundación de Investigación Biomédica, Madrid
Hospital Universitario La Paz, Madrid
Hospital Universitario Central de Asturias, Oviedo
Hospital Infanta Sofia, San Sebastián de los Reyes
Kyiv City Clinical Oncology Hospital, Kiev
Collaborators (1)
GlaxoSmithKline
INDUSTRY
European Association of Urology Research Foundation
OTHER